Evaluation of radioiodinated 1-[2-(3,4-Dimethoxyphenyl)ethyl]-4-(2-iodophenylpropyl)piperazine as a tumor diagnostic agent with functional sigma receptor imaging by single photon emission computed tomography.

MLA

Hirata, Masahiko, et al. “Evaluation of Radioiodinated 1-[2-(3,4-Dimethoxyphenyl)Ethyl]-4-(2-Iodophenylpropyl)Piperazine as a Tumor Diagnostic Agent with Functional Sigma Receptor Imaging by Single Photon Emission Computed Tomography.” Biological & Pharmaceutical Bulletin, vol. 31, no. 5, May 2008, pp. 879–83. EBSCOhost, https://doi.org/10.1248/bpb.31.879.

APA

Hirata, M., Mori, T., Umeda, T., Abe, T., Yamamoto, T., & Ohmomo, Y. (2008). Evaluation of radioiodinated 1-[2-(3,4-Dimethoxyphenyl)ethyl]-4-(2-iodophenylpropyl)piperazine as a tumor diagnostic agent with functional sigma receptor imaging by single photon emission computed tomography. Biological & Pharmaceutical Bulletin, 31(5), 879–883. https://doi.org/10.1248/bpb.31.879

Chicago

Hirata, Masahiko, Tetsuya Mori, Takuya Umeda, Takeshi Abe, Tomoya Yamamoto, and Yoshiro Ohmomo. 2008. “Evaluation of Radioiodinated 1-[2-(3,4-Dimethoxyphenyl)Ethyl]-4-(2-Iodophenylpropyl)Piperazine as a Tumor Diagnostic Agent with Functional Sigma Receptor Imaging by Single Photon Emission Computed Tomography.” Biological & Pharmaceutical Bulletin 31 (5): 879–83. doi:10.1248/bpb.31.879.